Summary
Camurus AB (Camurus), a subsidiary of Sandberg Development AB focuses on the development and commercialization of specialty medicines for the treatment of chronic diseases such as cancer and pain. The company offers its products through its proprietary FluidCrystal drug delivery technologies such as injection depot, topical bioadhesive delivery, and nanoparticle delivery technologies. Camurus’s products have therapeutic applications in the areas of cancer, endocrine disorders, pain, oral mucositis, metabolic disease, growth hormone disorders, and drug addiction. The company has developmental and commercial collaborations with biotechnology and pharmaceutical companies worldwide to exploit the potential of product development, proprietary drug delivery technologies and innovative products. Camurus is headquartered in Lund, Sweden.
Camurus AB (CAMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Camurus AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Camurus AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Camurus AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Camurus AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Camurus AB, Medical Devices Deals, 2011 to YTD 2017 9
Camurus AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Camurus AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Camurus Exercises Option For Licensing Agreement With Novartis For Octreotide 11
Licensing Agreements 12
R-Pharm Enters into Licensing Agreement with Camurus 12
Rhythm Pharma Enters into Licensing Agreement with Camurus 13
Solasia Pharma Enters into Licensing Agreement with Camurus for episil Oral Liquid 14
Camurus Expands Licensing Agreement with Braeburn Pharma 14
Camurus Enters Into Licensing Agreement With Cangene For Episil 16
Equity Offering 16
Camurus Completes IPO 16
Acquisition 18
Swedbank Robur Fonder Acquires 8.31% Stake in Camurus 18
Camurus AB - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Camurus AB, Pharmaceuticals & Healthcare, Key Facts 1
Camurus AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Camurus AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Camurus AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Camurus AB, Deals By Therapy Area, 2011 to YTD 2017 8
Camurus AB, Medical Devices Deals, 2011 to YTD 2017 9
Camurus AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Camurus Exercises Option For Licensing Agreement With Novartis For Octreotide 11
R-Pharm Enters into Licensing Agreement with Camurus 12
Rhythm Pharma Enters into Licensing Agreement with Camurus 13
Solasia Pharma Enters into Licensing Agreement with Camurus for episil Oral Liquid 14
Camurus Expands Licensing Agreement with Braeburn Pharma 14
Camurus Enters Into Licensing Agreement With Cangene For Episil 16
Camurus Completes IPO 16
Swedbank Robur Fonder Acquires 8.31% Stake in Camurus 18
Camurus AB, Key Competitors 19
Camurus AB, Key Employees 20
Camurus AB, Other Locations 21
Camurus AB, Subsidiaries 21
List of Figures
Camurus AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Camurus AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Camurus AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Camurus AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Camurus AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Camurus AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Camurus AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Camurus AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Camurus AB, Medical Devices Deals, 2011 to YTD 2017 9